1. Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations

   • John A. Nyman
   • Hawre J. Jalal

   Commentary 11 October 2012 Pages: 173 - 174

2. Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations

   • Pieter H.M. van Baal
   • Albert Wong
   • G. Ardine de Wit

   Leading Article 11 October 2012 Pages: 175 - 187

   

3. Sample Size and Power for Cost-Effectiveness Analysis (Part 1)

   • Henry A. Glick

   Practical Application 11 October 2012 Pages: 189 - 198

   

4. Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children

   • Chantal W.B. Boonacker
   • Pieter H. Broos
   • Maroeska M. Rovers

   Review Article 11 October 2012 Pages: 199 - 211

   

5. Advances in Cancer Therapeutics and Patient Access to New Drugs

   • George Dranitsaris
   • Ilse Truter
   • William Evans

   Review Article 11 October 2012 Pages: 213 - 224

   

6. Value of Information in the Osteoarthritis Setting

   • Nicholas Latimer
   • Joanne Lord
   • Philip G. Conaghan

   Original Research Article 11 October 2012 Pages: 225 - 237

   

7. Comparing Methods of Data Synthesis

   • Mark Oppe
   • Maiwenn Al
   • Maureen van Rutten-Mölken

   Original Research Article 11 October 2012 Pages: 239 - 250

   

8. Posaconazole

   • Katherine A. Lyseng-Williamson

   Adis Pharmacoeconomic Drug Evaluation 11 October 2012 Pages: 251 - 268